🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kohei Tsuji

Japan Research Institute

ORCID: 0000-0003-4773-8793

Also affiliated with Japan Space Forum

Biochemistry, Genetics and Molecular BiologyChemistryImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement”.

Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement

Chemical and Pharmaceutical Bulletin(2023)10.1248/cpb.c23-00562
N/A
0.330DataRank · unranked
8 citations

Takuya Kobayakawa, Takahiro Ishii, Nobuyo Higashi‐Kuwata, Chika Azuma, Kouki Shinohara +8 more

Chemically Programmable and Switchable CAR‐T Therapy

Angewandte Chemie(2020)10.1002/ange.202005432
N/A
0.312DataRank · unranked
7 citations

Kohei Tsuji, David Hymel, Terrence R. Burke, Michael Hudecek, Christoph Rader +2 more

A new genre of fluorescence recovery assay to evaluate polo-like kinase 1 ATP-competitive inhibitors

Analytical Methods(2020)10.1039/d0ay01223h
N/A
0.208DataRank · unranked
3 citations

David Hymel, Terrence R. Burke, Kohei Tsuji

Development of ultra-high affinity bivalent ligands targeting the polo-like kinase 1

RSC Chemical Biology(2022)10.1039/d2cb00153e
N/A
0DataRank · unranked
12 citations

David Hymel, Buyong Ma, Hirokazu Tamamura, Ruth Nussinov, Terrence R. Burke +1 more

Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates

Journal of Virology(2022)10.1128/jvi.01638-22
N/A
0DataRank · unranked
7 citations

Takeo Kuwata, William D. Tolbert, Jonathan Richard, Shilei Ding, Jérémie Prévost +12 more

Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2

Nature Communications(2023)10.1038/s41467-023-36729-0
N/A
0DataRank · unranked
45 citations

Kohei Tsuji, Hironori Hayashi, Haydar Bulut, Maki Kiso, Masaki Imai +30 more

Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115449
N/A
0DataRank · unranked
10 citations

Takuya Kobayakawa, Kouki Matsuda, Kohei Tsuji, Nami Ohashi, Shingo Nakahata +6 more

An orally available P1′-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier

PNAS Nexus(2024)10.1093/pnasnexus/pgae578
N/A
0DataRank · unranked
9 citations

Haydar Bulut, Hironori Hayashi, Kohei Tsuji, Hiromi Ogata-Aoki, Maki Kiso +23 more

Affinity enhancement of polo-like kinase 1 polo box domain-binding ligands by a bivalent approach using a covalent kinase-binding component

RSC Chemical Biology(2024)10.1039/d4cb00031e
N/A
0DataRank · unranked
5 citations

Hirokazu Tamamura, Terrence R. Burke, Kohei Tsuji

Application of a Fluorescence Recovery-Based Polo-Like Kinase 1 Binding Assay to Polo-Like Kinase 2 and Polo-Like Kinase 3

Biological and Pharmaceutical Bulletin(2024)10.1248/bpb.b24-00189
N/A
0DataRank · unranked
3 citations

Hirokazu Tamamura, Terrence R. Burke, Kohei Tsuji

Fine-tuning probes for fluorescence polarization binding assays of bivalent ligands against polo-like kinase 1 using full-length protein

Bioorganic & Medicinal Chemistry(2024)10.1016/j.bmc.2024.118055
N/A
0DataRank · unranked
2 citations

Hirokazu Tamamura, Terrence R. Burke, Kohei Tsuji

SARS-CoV-2 Papain-Like Protease Inhibitors Based on Naphthalen-1-ylethanamine and Halogenated Benzene Moieties

ACS Omega(2025)10.1021/acsomega.5c05856
N/A
0DataRank · unranked
2 citations

Takuya Kobayakawa, Kohei Tsuji, Yuki Takamatsu, Hiroaki Mitsuya, Hirokazu Tamamura +1 more

SARS-CoV-2 Main Protease Inhibitors Containing 5-Substituted Benzothiazole-2-carbonyl Moieties at the P1′ Site and Their Derivatives

ACS Omega(2025)10.1021/acsomega.5c05168
N/A
0DataRank · unranked
0 citations

Takuya Kobayakawa, Nobuyo Higashi‐Kuwata, Takahiro Ishii, Kouki Shinohara, Ryusei Yamamoto +5 more

Uncoupling the Folding-Function Paradigm of Lytic Peptides to Deliver Impermeable Inhibitors of Intracellular Protein–Protein Interactions

Journal of the American Chemical Society(2020)10.1021/jacs.0c07921
N/A
0DataRank · unranked
21 citations

Kohei Tsuji, Rachel P. M. Abrams, Terrence R. Burke, Joel P. Schneider, Stephen E. Miller

Application of HIV-1 viral protein R-derived-peptides as new E3 ligase-binding components of BRD4 degraders

RSC Chemical Biology(2025)10.1039/d5cb00125k
N/A
0DataRank · unranked
0 citations

Xueyuan Huang, Maho Miyamoto, Sayaka Sukegawa, Hidetomo Yokoo, Hiroaki Takeuchi +3 more

Chemically Programmable and Switchable CAR‐T Therapy

Angewandte Chemie International Edition(2020)10.1002/anie.202005432
N/A
0DataRank · unranked
44 citations

Kohei Tsuji, David Hymel, Terrence R. Burke, Michael Hudecek, Christoph Rader +2 more

Design and synthesis of a new orthogonally protected glutamic acid analog and its use in the preparation of high affinity polo-like kinase 1 polo-box domain – binding peptide macrocycles

Organic & Biomolecular Chemistry(2021)10.1039/d1ob01120k
N/A
0DataRank · unranked
10 citations

Kohei Tsuji, Robert A. Grant, Ramesh Chingle, Dominique L. Kunciw, Michael B Yaffe +2 more